Empirical Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9M Buy
90,031
+775
+0.9% +$181K 0.33% 60
2026
Q1
$21.8M Buy
89,256
+5,253
+6% +$1.22M 0.38% 48
2025
Q4
$17.4M Buy
84,003
+10,596
+14% +$2.1M 0.31% 58
2025
Q3
$13.6M Buy
73,407
+7,522
+11% +$1.29M 0.27% 73
2025
Q2
$10.1M Sell
65,885
-7,345
-10% -$1.13M 0.23% 91
2025
Q1
$12.1M Buy
73,230
+6,640
+10% +$1.04M 0.31% 62
2024
Q4
$9.63M Sell
66,590
-1,643
-2% -$255K 0.26% 80
2024
Q3
$11.1M Sell
68,233
-1,622
-2% -$258K 0.31% 69
2024
Q2
$10.2M Buy
69,855
+13,638
+24% +$2.03M 0.3% 68
2024
Q1
$8.89M Buy
56,217
+155
+0.3% +$24.7K 0.27% 76
2023
Q4
$8.79M Sell
56,062
-12,343
-18% -$1.89M 0.29% 67
2023
Q3
$10.7M Buy
68,405
+1,176
+2% +$194K 0.42% 52
2023
Q2
$11.1M Sell
67,229
-1,571
-2% -$254K 0.45% 45
2023
Q1
$10.7M Buy
68,800
+602
+0.9% +$97.2K 0.46% 41
2022
Q4
$12M Sell
68,198
-567
-0.8% -$97.9K 0.57% 35
2022
Q3
$11.2M Sell
68,765
-323
-0.5% -$54.7K 0.59% 35
2022
Q2
$12.3M Sell
69,088
-1,665
-2% -$297K 0.64% 33
2022
Q1
$12.5M Sell
70,753
-3,091
-4% -$526K 0.63% 33
2021
Q4
$12.6M Sell
73,844
-5,037
-6% -$825K 0.63% 34
2021
Q3
$12.7M Sell
78,881
-1,675
-2% -$286K 0.73% 32
2021
Q2
$13.3M Buy
80,556
+4,204
+6% +$696K 0.8% 28
2021
Q1
$12.5M Sell
76,352
-5,480
-7% -$887K 1.01% 19
2020
Q4
$12.9M Buy
81,832
+2,881
+4% +$425K 0.98% 20
2020
Q3
$11.8M Sell
78,951
-1,867
-2% -$276K 1% 20
2020
Q2
$11.4M Buy
80,818
+59,700
+283% +$8.7M 1.06% 18
2020
Q1
$2.77M Buy
21,118
+857
+4% +$122K 0.3% 51
2019
Q4
$2.96M Buy
20,261
+3,562
+21% +$483K 0.32% 47
2019
Q3
$2.16M Sell
16,699
-1,495
-8% -$197K 0.26% 64
2019
Q2
$2.53M Buy
18,194
+7,595
+72% +$1.05M 0.33% 42
2019
Q1
$1.48M Sell
10,599
-87
-0.8% -$11.7K 0.22% 70
2018
Q4
$1.38M Buy
10,686
+3,103
+41% +$433K 0.23% 59
2018
Q3
$1.05M Buy
7,583
+520
+7% +$69.1K 0.19% 66
2018
Q2
$857K Buy
7,063
+211
+3% +$26.3K 0.16% 76
2018
Q1
$878K Buy
6,852
+535
+8% +$72.3K 0.17% 71
2017
Q4
$883K Buy
6,317
+1,287
+26% +$179K 0.19% 59
2017
Q3
$654K Sell
5,030
-511
-9% -$67.7K 0.15% 74
2017
Q2
$733K Buy
5,541
+698
+14% +$89K 0.18% 62
2017
Q1
$603K Buy
4,843
+711
+17% +$84.9K 0.15% 74
2016
Q4
$476K Buy
4,132
+944
+30% +$109K 0.12% 78
2016
Q3
$377K Buy
3,188
+340
+12% +$41.2K 0.1% 82
2016
Q2
$345K Buy
2,848
+94
+3% +$10.7K 0.09% 84
2016
Q1
$298K Buy
2,754
+77
+3% +$7.97K 0.07% 92
2015
Q4
$275K Sell
2,677
-595
-18% -$59.8K 0.07% 90
2015
Q3
$305K Buy
3,272
+104
+3% +$10.1K 0.07% 91
2015
Q2
$309K Buy
+3,168
New +$317K 0.07% 100
2015
Q1
Sell
-2,465
Closed -$258K 103
2014
Q4
$258K Sell
2,465
-199
-7% -$21K 0.06% 89
2014
Q3
$284K Buy
2,664
+301
+13% +$31.2K 0.07% 85
2014
Q2
$247K Buy
2,363
+1
+0% +$101 0.06% 87
2014
Q1
$232K Buy
2,362
+134
+6% +$12.4K 0.06% 91
2013
Q4
$204K Sell
2,228
-106
-5% -$9.77K 0.06% 89
2013
Q3
$202K Buy
+2,334
New +$209K 0.06% 87

Other funds holding JNJ

Empirical Wealth Management's JNJ Position: Q2 2026 in Review

Empirical Wealth Management increased its Johnson & Johnson (JNJ) stake by 0.87% in Q2 2026, buying an estimated $181K and bringing the position to 90,031 shares worth $22.9M. The position accounts for 0.33% of the portfolio, ranked #60.

Empirical Wealth Management first reported a position in JNJ in Q3 2013 and has held it in 51 quarters since. 2,088 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Empirical Wealth Management held 90,031 shares of Johnson & Johnson worth $22.9M as of Q2 2026.
  • Empirical Wealth Management bought 775 Johnson & Johnson shares in Q2 2026, an estimated $181K.
  • Johnson & Johnson made up 0.33% of Empirical Wealth Management's portfolio in Q2 2026, its #60 holding.
  • Empirical Wealth Management first reported a position in Johnson & Johnson in Q3 2013 and has held it in 51 quarters since.
  • 2,088 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.